A-fib and Occlusion - renal artery

Summary:

Occlusion - renal artery is found among people with A-fib, especially for people who are male, 60+ old.

The study analyzes which people have Occlusion - renal artery with A-fib. It is created by eHealthMe based on reports of 27 people who have A-fib from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Jan, 29, 2023

27 people who have A-Fib and Occlusion - Renal Artery are studied.


What is A-fib?

A-fib (most common type of arrhythmia) is found to be associated with 3,641 drugs and 3,458 conditions by eHealthMe.

What is Occlusion - renal artery?

Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) is found to be associated with 1,225 drugs and 704 conditions by eHealthMe.

Number of Occlusion - renal artery in A-fib reports submitted per year:

Would you have Occlusion - renal artery when you have A-fib?

Gender of people who have A-Fib and experienced Occlusion - Renal Artery *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have A-Fib and experienced Occlusion - Renal Artery *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 4.55 %
  • 60+: 95.45 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 4 people, 14.81%
  2. Parkinson's Disease: 4 people, 14.81%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 11.11%
  4. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 11.11%
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 7.41%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 7.41%
  7. Metabolic Syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease): 2 people, 7.41%
  8. Type 2 Diabetes: 2 people, 7.41%
  9. Cardiac Failure: 1 person, 3.70%
  10. Cardiac Failure Chronic: 1 person, 3.70%

Common drugs taken by these people *:

  1. Lasix: 9 people, 33.33%
  2. Plavix: 9 people, 33.33%
  3. Pradaxa: 8 people, 29.63%
  4. Aspirin: 8 people, 29.63%
  5. Digoxin: 6 people, 22.22%
  6. Cordarone: 5 people, 18.52%
  7. Coumadin: 4 people, 14.81%
  8. Xarelto: 4 people, 14.81%
  9. Menest: 4 people, 14.81%
  10. Levothyroxine Sodium: 4 people, 14.81%

Common symptoms for these people *:

  1. Renal Failure Acute (rapid kidney dysfunction): 10 people, 37.04%
  2. Cardiac Failure Congestive: 7 people, 25.93%
  3. Haemorrhage (bleeding): 6 people, 22.22%
  4. Tricuspid Valve Incompetence (inefficient heart valve): 6 people, 22.22%
  5. Mitral Valve Incompetence (inefficient heart valve): 6 people, 22.22%
  6. Anaemia (lack of blood): 6 people, 22.22%
  7. Oedema Peripheral (superficial swelling): 5 people, 18.52%
  8. Atrioventricular Block First Degree (heart block first degree): 5 people, 18.52%
  9. Urinary Tract Infection: 5 people, 18.52%
  10. Fatigue (feeling of tiredness): 5 people, 18.52%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Occlusion - renal artery?

Check whether Occlusion - renal artery is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Occlusion - renal artery:

Common drugs associated with Occlusion - renal artery:

All the drugs that are associated with Occlusion - renal artery:

Common conditions associated with Occlusion - renal artery:

All the conditions that are associated with Occlusion - renal artery:

How the study uses the data?

The study is based on Occlusion - renal artery and A-fib, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: